Dexamethasone attenuates LPS-induced changes in expression of urea transporter and aquaporin proteins,ameliorating brain endotoxemia in mice |
| |
Authors: | Yanwei Du Yan Meng Xuejiao Lv Lirong Guo Xiaoqin Wang Zhenzhong Su Lu Li Na Li Shuhua Zhao Lijing Zhao Xuejian Zhao |
| |
Affiliation: | 1Department of Pathophysiology, Key Laboratory of Pathobiology, College of Basic Medicine, Jilin University, Changchun 130021, China;2Second Hospital of Jilin University, Changchun 130041, China;3Changchun University of Chinese Medicine, Changchun 130117, China |
| |
Abstract: | Aim: AQP4 in the brain is involved in the occurrence and development of a variety of encephalopathy. AQPs family changes in kidney were accompanied by altered UTs family. The aim of this study was to observe AQP4 and UT-A3 expression in CNS and to explore their role in the pathogenesis of endotoxemia encephalopathy following peripheral LPS injection in mice. Methods: Endotoxemia was induced in C57Bl/6 mice by intraperitoneal injection of LPS. The expression of UT-A3 and AQP4 in brain were detected by Western blot and immunohistochemistry, the level of cytokines were detected by ELISA, and the content of LDH, AST/ALT, BUN and CREA were detected by colorimetric method. Results: As compared with the control group, in model group, the brain weight/ body weight ratio increased by 13%. Meanwhile, a 2.5 fold increase in LDH and a 1.2 fold increase in AST/ALT were found in peripheral serum (P < 0.05), and also, BUN and CREA increased 2.5 fold (P < 0.01). In addition to severe CNS injury in response to lipopolysaccharide, the contents of cytokines and the expression of AQP4 protein in hippocampal is increased (P < 0.05), while the expression of UT-A3 protein in the hippocampus and cortical astrocytes decreased (P < 0.05). And, in part, Dexa pretreatment attenuated those effects. Conclusions: In endotoxemia encephalopathy, AQPs and UTs which regulate the functions of cell membrane are both altered. We suggested that the molecular mechanisms of regulation in endotoxemia may provide a new strategy for clinical treatment of the disease and drug binding sites. |
| |
Keywords: | Lipopolysaccharide (LPS) urea transporters (UTs) aquaporins (AQPs) dexamethasone (Dexa) brain |
|
|